epigenetic therapy
Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
... We have discovered ZAR1 as a potential cancer bio- marker, which should be followed by assay development and analytical validation, clinical utility validation, and ul- timately clinical implementation [42]. We suggest ...
16
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
... studied epigenetic modifications, although ethyl, acetyl, phosphoryl, and other modifications of histones have been described ...for epigenetic therapy of ...
11
Harnessing the potential of epigenetic therapy to target solid tumors
... of epigenetic therapy into account must be used in developing new ...to epigenetic therapy may be the most important arbiter of the extent to which epigenetic therapies are pursued or ...
9
Dual Epidermal Growth Factor Inhibition and Multi Targeted Epigenetic Therapy (MTET)
... the epigenetic silencing and to EGFR TKI resistance in NSCLC [3] ...combinational therapy that targets the EGFR molecule, (by small molecule inhibitor, Afatanib) with simultaneous epigenetic ...
11
Epigenetic Tumor Response to Hypoxia: An Epimutation Pattern and a Method of Multi Targeted Epigenetic Therapy (MTET)
... We showed a sensitizing effect of Quercetin on cells, when they were pretreated 6 - 24 hours before exposure to SPB. In this experiment, reduction of dose necessary to inhibit HIF was seen up to 50 percent. We correlated ...
16
Biological Modulation of Parp Inhibition in Triple Negative Breast Cancer, a Combinational Approach Implementing Multitargeted Epigenetic Therapy (Mtet) with Parp Inhibition, in Advanced Breast Cancer: A Case Study
... the therapy fails ...immune therapy and interestingly relevant to this article, epigenetic therapies ...combinational therapy, con- sisting of PARP inhibitor and epigenetic ...the ...
11
Epigenetic therapy for ovarian cancer: promise and progress
... combining epigenetic and immune therapies: in a syngeneic ovarian cancer mouse model, a combination of decitabine and anti-CTLA-4 significantly reduced tumor growth and prolonged survival compared to each drug ...
11
Predicting response to epigenetic therapy
... likely that each individual drug will require a specific biomarker. Third, epigenetic drugs are being used in combination, which may further complicate the identification of relevant biomarkers. Fourth, each ...
10
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
... by epigenetic therapy in NSCLC, we analysed gene expression and promoter methylation in reprogrammed NSCLC cell lines ...because epigenetic therapies targets both, suitable data sets were not ...
11
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
... Given the association of these genes with other can- cers, perturbations of their mRNA or protein levels could account for or contribute to the association with prognosis in AML or outcome of 5-AZA therapy in MDS ...
18
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
... for therapy success that the treatment kills tumor cells, and not just arrests them during the cell cycle, we next assessed whether KDM1A knockdown induced apoptosis in medulloblas- toma ...
13
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management
... adapt epigenetic machinery to their advantage has also improved understanding of how cancers develop chemoresistance to existing ...with epigenetic agents to restore the impact of conventional drugs has ...
10
Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer
... with epigenetic factors in inducing ER-dependent oncogenesis and thus cell ...between epigenetic regulation and hormone signaling provide an avenue for combination therapy of ER-positive breast ...
9
Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease
... OF EPIGENETIC THERAPY Whereas genetic mutations and chro- mosomal defects permanently alter the genome, epigenetic alterations, whether driven by changes to the underlying ge- nome or by ...
10
Epigenetics of hepatocellular carcinoma
... by epigenetic processes have also been implicated in process of hepatic tumori- genesis, making them rational targets for miRNA-based strategies in epigenetic ...
15
<p>DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses</p>
... The two most classic drug classes used in epigenetic therapy are DNMTi and histone deacetylase inhibitors (HDACi). 27 DNMTs are key enzymes that catalyse DNA methylation, mainly DNMT1, DNMT3A, and DNMT3B. ...
14
Control of viral infections by epigenetic-targeted therapy
... Furthermore, epigenetic therapy could exemplify the “two birds, one stone” concept in the scenario of viral co-infection, ...global epigenetic modifications and complicates the achievement of a ...
17
Aberrant DNA Methylation in Cholangiocarcinoma
... cholangiocarcinoma. Epigenetic therapy with DNA methylation inhibitors hold considerable promise for the treatment of cholangiocarcinoma through re-activation of tumor suppressor genes and miRNAs as well as ...
10
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
... H358 and A549 cell lines were selected for their ability to form distinct colonies on a reconstituted basement membrane matrix (Matrigel). Using the treatment paradigm previously described, we pretreated cells with ...
15
Cross talk between Epigenetics and Human Disease-A multifaceted review
... involve epigenetic changes that contribute to these disorders and they manifest at a very young age 9 ...Both epigenetic and genetic factors are often important in human imprinting disorders and the ...
12